News & Spotlights, NNE-CTR, Larner College of Medicine, UVM

News Bits ...

Call for Proposals: 2024 Health Equity Summit

Discover and share exciting initiatives at the third annual Health Equity Summit, Building Solidarity: Sustainable Pathways Towards Health Equity. The Summit is a collaboration between community members, healthcare providers and educators to dismantle institutional barriers to health and enhance patient experiences.

Details

Dates: Monday, October 7, 4 - 6 pm: Poster presentations and kickoff reception

Tuesday, October 8, 8 am - 5 pm: Workshops and sessions

Location: Double Tree Hotel, 870 Williston Road, South Burlington, VT 05403 (Google Maps)

Sponsors: The 3rd Annual Health Equity Summit is a joint effort presented by the University of Vermont Health Network, the Larner College of Medicine, the College of Nursing and Health Sciences, and the University of Vermont.

More information: Health Equity Summit | The University of Vermont Health Network (uvmhealth.org)

Questions? Please email HESummit@uvmhealth.org

Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

Holmes Discusses Using Genetics to Predict Clot Risk

January 3, 2017 by Michael Carrese

Among the side effects experienced by cancer patients undergoing chemotherapy is a higher risk of blood clots, but determining which patients are most likely to get them is a challenge for physicians.
Sigmon Reports on Study of Waitlisted Opioid-Dependent Adults in NEJM

January 3, 2017 by Jennifer Nachbur

In rural states like Vermont, opioid-dependent adults desperate for treatment often find themselves stuck on a wait list, sometimes for eight months or more, increasing their risk of continuing to use illicit opioids, contract an infectious disease, overdose and prematurely die.
Janssen-Heininger Receives Inaugural NHLBI Outstanding Investigator Award

December 21, 2016 by Jennifer Nachbur

Antioxidant therapies may hold promise for the nearly 25 million Americans suffering from asthma, and additional 140,000 people diagnosed with pulmonary fibrosis, but to date, determining exactly how to modify them into a feasible treatment has proved challenging.
College Holds Investiture of First Philip Ades, M.D. Professor of Cardiovascular Disease Prevention

December 16, 2016 by Jennifer Nachbur

University of Vermont President Tom Sullivan and Larner College of Medicine Dean Frederick Morin, M.D., invested Philip Ades, M.D., professor of medicine and director of cardiac rehabilitation and preventive medicine, as the inaugural Philip Ades, M.D. Professor of Cardiovascular Disease Prevention December 16, 2016. The ceremony, hosted by the UVM Foundation, took place in the Hoehl Gallery in the Health Science Research Facility.
Meet a Scientist: Colgate Examines Rotavirus Vaccine Efficacy in Non-U.S. Countries

December 16, 2016 by Erin Post

UVM Vaccine Testing Center researcher E. Ross Colgate, M.P.H., spent two years working in Bangladesh trying to understand why a rotavirus vaccine that prevents the majority of cases in the U.S. works only 40 to 60 percent of the time in Bangladeshi infants. Finding an answer could save hundreds of thousands of lives given rotavirus’ status as the leading cause of diarrhea in young children worldwide, among whom diarrhea is the second leading cause of death.

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.